ELUT - Elutia Inc.
Elutia Inc. Logo

ELUT - Elutia Inc.

https://elutia.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Elutia Inc., a commercial-stage company, engages in developing and commercializing drug-eluting biomatrix technology to enhance surgical outcomes. The company is headquartered in Silver Spring, Maryland.

52W High
$5.12
52W Low
$1.61
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.89
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-3.33
EV/Revenue (<3 favorable)
4.20
P/S (TTM) (<3 favorable)
3.37
P/B (<3 favorable)
N/A
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
2.20%
Institutions (25–75% balanced)
70.65%
Shares Outstanding
38,081,900
Float
15,385,300
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
As of 2025-06-30 (Overview)
Revenue (TTM)
23,683,000
Gross Profit (TTM)
10,580,000
EPS (TTM)
-0.43
Profit Margin (>10% good)
-0.90%
Operating Margin (TTM) (higher better)
-0.94%
ROE (TTM) (>15% strong)
N/A
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.00
Momentum
Bearish momentum
Value
-0.2276
Previous
-0.1915
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025